Elizabeth Dolan
Procter & Gamble (United States)(US)
Publications by Year
Research Areas
Exercise and Physiological Responses, Stress Responses and Cortisol, Adipose Tissue and Metabolism, Muscle Physiology and Disorders, Fibromyalgia and Chronic Fatigue Syndrome Research
Most-Cited Works
- → Widespread cutaneous and systemic calcification (calciphylaxis) in patients with the acquired immunodeficiency syndrome and renal disease(1992)80 cited
- → MALDI-TOF MS as a label-free approach to rapid inhibitor screening(2006)61 cited
- → Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy(2005)44 cited
- → Influence of lovastatin on concentrations and composition of lipoprotein subfractions(1990)23 cited
- → Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice(2007)19 cited
- → ICAT-MS-MS time course analysis of atrophying mouse skeletal muscle cytosolic subproteome(2005)16 cited
- → Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions(2011)15 cited
- → Modifications of the human urocortin 2 peptide that improve pharmacological properties(2006)10 cited
- → The synthesis and evaluation of indolylureas as PKCα inhibitors(2011)6 cited
- → Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animals(2011)4 cited